Arbutus Biopharma Corporation is a leading biopharmaceutical company that specializes in discovering, developing, and commercializing innovative therapies to treat liver diseases. With a focus on RNA interference (RNAi) and other technologies, Arbutus is at the forefront of cutting-edge research and development in the field. Its commitment to improving patient outcomes and advancing the field of medicine makes it a key player in the industry.
